Search

everythinglearnresearchcommunity

for

Search:↓

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Chlorinated compounds like TCDD can cause skin issues and chloracne by affecting cell behavior.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

CS12192 effectively treats alopecia areata with better safety than current options.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Danthron from Rhubarb causes melanoma cells to stop growing and die.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

The treatment is safe and shows promise for metastatic breast cancer.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.